MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Change in Cash
-$524,658
Unit: Dollar
Positive Cash Flow Breakdown
    • Accrued compensation
    • Stock-based compensation expense
    • Depreciation and amortization
    • Allowance for doubtful accounts
Negative Cash Flow Breakdown
    • Net loss
    • Investment in capitalized softwa...
    • Accounts receivable
    • Others
Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Impairment of capitalized software
-
-
-
90,869
Net revenue
-
-
-
110,459
Interest income
-
-
-
77,396
Impairment of capitalized software
-
-
-
90,869
Stock-based compensation expense
-
-
-
226,053
Advertising and marketing expenses
-
-
-
174,227
Depreciation and amortization, net of deferred costs
-
-
-
55,503
Professional fees
-
-
-
591,918
Personnel-related expenses
-
-
-
1,823,715
Director restricted stock unit expense
-
-
-
300
Warrants issued for underwriting fee
-
-
-
95,984
Technology and development expense
-
-
-
69,478
Other segment items
-
-
-
377,193
Segment net loss
-
-
-
-3,617,086
Net loss
-678,061
-732,548
-642,266
-3,617,086
Depreciation and amortization
71,373
67,740
60,440
433,803
Stock-based compensation expense
72,252
72,252
72,252
226,053
Warrants issued for underwriting fee
-
-
-
95,984
Forfeiture of accrued director compensation
-
-
-
-200,000
Allowance for doubtful accounts
7,964
-
-
-
Accounts receivable
19,742
-3,147
4,003
-23,719
Prepaid expenses and other current assets
3,136
93,828
-28,771
-309,389
Accounts payable
-6,583
5,530
-6,051
-23,494
Accrued compensation
118,925
71,717
133,858
209,813
Deferred revenue
-12,150
-8,530
-12,090
36,745
Other accrued liabilities
0
-6,564
-46,676
-41,043
Net cash and cash equivalents used in operating activities
-449,158
-621,084
-415,765
-2,455,248
Investment in capitalized software
75,500
43,600
87,600
378,300
Net cash and cash equivalents used in investing activities
-75,500
-43,600
-87,600
-378,300
Proceeds from the sale of common stock
-
-
-
3,095,950
Net cash and cash equivalents provided by financing activity
-
-
-
3,095,950
Net increase (decrease) in cash, cash equivalents, and restricted cash
-524,658
-664,684
-503,365
262,402
Cash and cash equivalents at beginning of period
-
1,930,053
2,433,418
2,171,016
Cash and cash equivalents at end of period
-
1,265,369
1,930,053
2,433,418
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Net increase(decrease) in cash, cash...-$524,658 Accrued compensation$118,925 Stock-based compensationexpense$72,252 Depreciation andamortization$71,373 Allowance for doubtfulaccounts$7,964 Net cash and cashequivalents used in...-$449,158 Net cash and cashequivalents used in...-$75,500 Canceled cashflow$270,514 Net loss-$678,061 Investment in capitalizedsoftware$75,500 Accounts receivable$19,742 Deferred revenue-$12,150 Accounts payable-$6,583 Prepaid expenses andother current assets$3,136

Amesite Inc. (AMST)

Amesite Inc. (AMST)